Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Cash from Financing Activities (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Cash from Financing Activities for 7 consecutive years, with $6.9 million as the latest value for Q4 2024.

  • Quarterly Cash from Financing Activities rose 1274.26% to $6.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $122.4 million through Dec 2024, up 62.73% year-over-year, with the annual reading at $194.4 million for FY2025, 58.81% up from the prior year.
  • Cash from Financing Activities hit $6.9 million in Q4 2024 for Solid Biosciences, up from $3.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $135.2 million in Q1 2021 to a low of -$238000.0 in Q2 2021.
  • Historically, Cash from Financing Activities has averaged $25.6 million across 4 years, with a median of $505000.0 in 2023.
  • Biggest YoY gain for Cash from Financing Activities was 113137.88% in 2022; the steepest drop was 133.33% in 2022.
  • Year by year, Cash from Financing Activities stood at $66000.0 in 2021, then soared by 113137.88% to $74.7 million in 2022, then tumbled by 99.32% to $505000.0 in 2023, then surged by 1274.26% to $6.9 million in 2024.
  • Business Quant data shows Cash from Financing Activities for SLDB at $6.9 million in Q4 2024, $3.3 million in Q3 2024, and $5.0 million in Q2 2024.